Tag: Ysios Capital
Tagworks Pharmaceuticals bags $65m in Series A for Click-to-Release technology
Tagworks Pharmaceuticals BV, a Netherlands-based pioneer in Click-to-Release chemistry that promotes more effective and safer systemic therapies, has secured $65 million in Series A funding. ... Read More
Aura Biosciences raises $80m for VDC therapies for cancers
Aura Biosciences, a portfolio company of UK-based Arix Bioscience, has raised $80 million in a new funding round for developing virus-like drug conjugate (VDC) therapies ... Read More
Galecto Biotech raises €79m to launch idiopathic pulmonary fibrosis trial
Galecto Biotech, a Denmark-based pharma company focused on developing galectin modulators for the treatment of severe diseases such as idiopathic pulmonary fibrosis and cancer, has ... Read More